Areas of Abstract Submission


Submission of abstracts in the following areas is encouraged:

Please note these areas of submission will be categorized into ACCP’s following tracks:

  1. Basic Research & Drug Development
  2. Patient Centric
  3. Both: Basic Research/Drug Development & Patient Centric
  • Adverse Drug Effects
  • Antisense Oligonucleotide & siRNA Modalities
  • Applications of Modeling & Simulation
  • Artificial Intelligence
  • Big Data Science & Healthcare Analytics
  • Biologics & Therapeutic Proteins
  • Biomarkers
  • Biopharmaceutics
  • Biosimilars & Generics
  • Botanical Drug Development
  • Cell-based Therapeutics
  • Clinical Pharmacology Education
  • Clinical Trials
  • Combination Drug Development
  • Decision Making in Research & Development
  • Digital Health
  • Disease Management
  • Drug Dependence
  • Drug Interactions
  • Drug Metabolism & Transporters
  • Drug Safety and/or Efficacy
  • Imaging
  • Immunology/Immunotherapy
  • In Vitro/In Vivo Extrapolation
  • Infectious Diseases including HIV/AIDS & COVID-19
  • Inflammatory Diseases
  • Innovative Statistical Methods
  • Interprofessional Communication/Teams
  • Machine Learning
  • Mechanism of Action
  • Metabolic Diseases
  • Model-informed Drug Development
  • Neurology
  • New & Adaptive Clinical Trial Designs
  • Novel Use of Therapeutics/Drug Repurposing
  • Oncology/Immuno-oncology
  • Other (specify)
  • Pain Management
  • Pharmacodynamics
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Pharmacogenomics
  • Pharmacokinetics (ADME)
  • Pharmacovigilance
  • Physiologically-based Pharmacokinetics
  • Population Pharmacokinetics
  • Precision Medicine
  • Quality of Life
  • Rare Diseases
  • Real-world Evidence in Decision Making
  • Regulatory Science
  • Risk Management/Legal Issues
  • Special Populations in Clinical Trials, e.g. Pediatrics, Geriatrics
  • Systems Pharmacology
  • Technology Platforms in Drug Development
  • Therapeutic Drug Monitoring
  • Thrombosis/Hemostasis
  • Translational Medicine
  • Women’s Health

Primary criteria for acceptance of abstracts are:

  • Applicability to clinical pharmacology and translational medicine;
  • Innovation and scientific merit;
  • Relevance to ACCP's mission.

Each abstract must contain:

  • A statement of purpose, innovation or hypothesis;
  • Description of methods and materials;
  • Data and results;
  • Interpretation, conclusion and significance.